Sunovion Pharmaceutical just introduced a new medication to treat Chronic Obstructive pulmonary disease (COPD). The new Seebri™ Neohaler® delivers glycopyrrolate into the lungs for the long term maintenance of COPD including both chronic bronchitis and emphysema.
Glycopyrrolate is an anticholinegic agent which will ease airflow obstruction by allowing the muscles of the airways to relax. When the muscles relax, the airways open to allow more air to flow into the lungs. This medication is a long term maintenance treatment for COPD and should not be used for a sudden attack.
Sunovion Pharmaceuticals has introduced the new medication in conjunction with a savings program designed to make the product more affordable. Consult your doctor to see if Seebri Neohaler would be appropriate treatment for you.
About Seebri™ Neohaler®
Seebro™ Neohaler® is an inhaled glycopyrrolate powder. It will relax the muscles in the lungs that surround the airways. When these muscles relax, the airway opens, allowing more air to flow into the lungs. Glycopyrrolate is intended to be used as a long term treatment of COPD. It needs to be used twice daily (or as directed by your doctor). Because it is a long term treatment, it will not relieve a sudden attack of COPD. You should always have a rescue inhaler for such attacks.
When you first start using a Neohaler™ you want to familiarize yourself with the proper technique. You can find an instructional video below to help you understand the steps for proper use. You can get more information about the inhaler at the manufacturer website. https://www.seebri.us/
Seebri™ Savings Program
Sunovion is offering substantial savings on their Seebri™ Neohaler® to help more people get this life saving treatment. There are two parts to the savings program.
First, new patients can get a free trial of the medication. Those who qualify can get their first prescription of Seebri™ for free. By allowing new patients to try the inhaler at no charge, they can see how well it works and if they notice any side effects with no out of pocket costs.
Second, qualified patients who will be on this medication long term can benefit from a program offering up to a $250 monthly savings. The result can be a copay as low as $0 for people with commercial insurance.
As is common with these programs, there are restrictions. Those with commercial insurance will potentially benefit the most. People covered under state or federal programs such as Medicare and Medicaid do not qualify for this offer. For more information about the savings program you can visit the Seebri™ website.
COPD treatment at an affordable price
Managing COPD is very challenging and the costs associated with the treatment options can be a burden. Fortunately there are effective treatments combined with manufacturer saving programs. The Seebri™ savings cards provided by Sunovion make it possible for more people to get their COPD under control without breaking the bank.
If you are just starting on the Seebri™ Neohaler® please be sure you understand the proper use of the device in order to get the most benefit from this medication. This video should help you get a better understanding of the proper technique.